Dr. Voineskos is Director of the Slaight Family Centre for Youth in Transition and Head of the Kimel Family Translational Imaging-Genetics Laboratory in the Campbell Family Mental Health Research Institute at CAMH. He is Chief of the Schizophrenia Division at CAMH, a Canada Research Chair in Neuroimaging of Schizophrenia, and Professor of Psychiatry at the University of Toronto.
Areas of Research
Dr. Voineskos holds a special interest in leading and planning multi-centre research. He currently holds operating funding as Principal Investigator from the NIMH, CIHR, CFI, and University of Toronto.
In the Kimel Lab, Dr. Voineskos’s work with scientists and trainees uses multi-modal neuroimaging across the lifespan in mental illnesses such as schizophrenia, bipolar disorder, autism, and Alzheimer's disease to understand changes in brain circuitry in relation to behaviour. Advanced neuroimaging techniques are also applied in treatment studies to understand effects of interventions on brain structure and function, and predict response. Novel work is now aimed toward understanding subgroup and individual brain profiles in relation to behaviour and treatment planning.
For more information, view the Kimel Family Lab page.
In the Slaight Centre, Dr. Voineskos works with a number of other scientists and team-members to identify biomarkers of early signs of psychosis, improving service delivery for youth with early psychosis, and working with youth, family, policy makers, researchers, and clinicians to effect health system change for those dealing with psychosis or schizophrenia.
For more information visit the Slaight Family Centre for Youth in Transition page.
View Dr. Voineskos' publications on PubMed.